Medication Management
Expert articles and analysis related to medication management.
AI Summary — Last 24 Hours
Employers are accelerating pressure on the Big Three PBMs, with a new survey finding many are considering switching vendors as affordability and drug-price transparency become purchasing priorities—an immediate signal to ACOs, payers, and risk-bearing providers that pharmacy benefit design will face more scrutiny in total-cost-of-care contracts (MedCity News). At the same time, pharmacist-led medication reconciliation is gaining evidence as a near-term quality and safety lever, with orthopedic discharge reconciliation reducing medication errors—relevant for VBC organizations managing avoidable readmissions, post-acute transitions, and Stars/quality performance (Drug Topics). GLP-1 affordability and telehealth access remain active management issues, reinforcing the need for formularies, prior authorization, and longitudinal medication management strategies that balance outcomes, equity, and budget risk.
Related Articles
Q&A: FTC Settlements, PBM Reform Are Reshaping Transparency Standards
Report: Employers’ Use of Big Three PBMs Falls in 2026
A new survey finds that employers are moving away from the Big Three PBMs while prioritizing healthcare affordability and transparency. The post Report: Employers’ Use of Big Three PBMs Falls in 2026 ...
The most affordable GLP-1s: Generics and insurance coverage
The most affordable GLP-1s: Generics and insurance coverage  Optum Perks
56% of employers using Big 3 PBMs consider switch
56% of employers using Big 3 PBMs consider switch  Becker's Payer Issues
Pharmacist-Led Discharge Reconciliation Reduces Orthopedic Medication Errors
Dispensary of Hope Delivers Free Medicines to Uninsured Patients
OCTOPUS Trial Aims to Speed Access to Rare Sarcoma Drugs
Psychedelics Medicine: The Real Bottleneck Isn’t The FDA
Psychedelics Medicine: The Real Bottleneck Isn’t The FDA  Optum Business
Leucovorin Dispensing to U.S. Children in 2025
Leucovorin Dispensing to U.S. Children in 2025Â Â The New England Journal of Medicine
A guide to switching or stopping GLP-1s
A guide to switching or stopping GLP-1s  Optum Perks